[Vaquez disease. Diagnosis, course, treatment].
Bauters
F
F
Service des maladies du sang, hôpital Huriez, CHRU, Lille.
D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000986:Antisickling Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007275:Injections, Intravenous; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage; D010885:Pipobroman / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors; D012737:Sex Factors
D018906:Antineoplastic Agents, Alkylating; D000986:Antisickling Agents; D016898:Interferon-alpha; D010761:Phosphorus Radioisotopes; D010885:Pipobroman; D006918:Hydroxyurea